Appointments

David Loose has been appointed as chief executive officer of Essex Management, part of contract research organisation Emmes Group.

After joining as a partner of Essex Management in 2009, David has served various roles in upper management to aid the growth of the company. He has progressed from vice president of Business Operations and Development to chief business officer. In this role, he was tasked with overseeing critical operations and enforcing the National Cancer Institute’s Clinical Trials Reporting Program, strengthening strategic initiatives at the company.

Chief executive officer of Emmes Group Sastry Chilukiri stated: “David’s leadership and dedication to Essex’s mission make him the ideal choice to guide the company forward. His focus on innovation and client success will ensure Essex continues to deliver transformative solutions in biomedical informatics and health information technology.”

Ex-CEO Kevin Hurley, who now takes up the role of executive advisor to the company, was thanked for his service by David Loose: “We are deeply grateful for Kevin’s leadership and dedication over the years. His vision has been instrumental in Essex’ success, and we’re fortunate to have his continued guidance as an executive advisor.”